Neman-Ebrahim Yousha
Chief Clinical Officer
Neman-Ebrahim Yousha has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Apr 24, 2026.
On the most recent filing, Neman-Ebrahim Yousha is listed as Chief Clinical Officer at NEONC TECHNOLOGIES HOLDINGS, INC. Inside the rolling window, Neman-Ebrahim Yousha reported 2 open-market purchases totaling $10K in NTHI and no open-market sales. The largest disclosed transaction in the window is a purchase of 1,100 NTHI shares on Nov 20, 2025, worth $7K.
Companies traded
Other insiders at NTHI
Insider Buying
$10K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Neman-Ebrahim Yousha made?
Neman-Ebrahim Yousha has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Neman-Ebrahim Yousha trade?
Neman-Ebrahim Yousha has filed SEC Form 4 disclosures for 1 company, including NTHI.
When was Neman-Ebrahim Yousha's most recent SEC Form 4 filing?
Neman-Ebrahim Yousha's most recent SEC Form 4 filing on Tracefour is dated Apr 24, 2026.
What is Neman-Ebrahim Yousha's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Neman-Ebrahim Yousha is listed as Chief Clinical Officer.
What is Neman-Ebrahim Yousha's total buy and sell value in the current window?
Inside the rolling retention window, Neman-Ebrahim Yousha bought $10K and sold $0 based on SEC Form 4 filings.
What was Neman-Ebrahim Yousha's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,100 NTHI shares on 2025-11-20, worth $7K, per SEC Form 4 filings.